Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,147
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Wyomissing PA, Philadelphia PA, Danville PA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06843590
Phase2, Recruiting
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
for
Asthma
Location: Wyomissing PA, Burke VA, DuBois PA, Kissimmee FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12+
Code: NCT07456033
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
for
Narcolepsy Type 1
Location: Wyomissing PA, Middletown NJ, Newton MA, Toronto,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07455383
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Wyomissing PA, Newton MA, Toronto, Markham, Novi MI,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07502443
Phase3, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Wyomissing PA, Abington PA, Middletown NJ, Canton OH,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Flemington NJ, Willow Grove PA, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase2, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Flemington NJ, Wynnewood PA, Philadelphia PA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Flemington NJ, Philadelphia PA, Toms River NJ,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)